Elizabeth Charuvastra Exemption Trust insider trades: Targeted Medical Pharma (TRGM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elizabeth Charuvastra Exemption Trust reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2014 | TRGM | ↓ Sell | 101,035 | $0.40 | $40K | By Trust | Aug 21, 2014 (9d) |
| Jul 24, 2014 | TRGM | ↓ Sell | 398,965 | $0.40 | $160K | By Trust | Aug 21, 2014 (28d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Elizabeth Charuvastra Exemption Trust's insider trades
Elizabeth Charuvastra Exemption Trust is CEO & Chief Scientific Officer at Targeted Medical Pharma (TRGM). Since Jul 24, 2014, it has reported no open-market purchases and 2 sales worth $200K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include inherited shares (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRGM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.